Nabriva Therapeutics plc Total Liabilities
Nabriva Therapeutics plc had Total Liabilities of $26.90 million as of 2023-06-30, per its 10-Q filed 2023-10-19.
Discontinued › Balance Sheet › Liabilities
us-gaap:Liabilities · last filed 2023-10-19
- 2023-06-30: Liabilities $26.90M.
- 2023-03-31: Liabilities $28.70M.
- 2022-12-31: Liabilities $28.47M.
- 2022-09-30: Liabilities $22.62M.
| Period end | Liabilities |
|---|---|
| 2023-06-30 | $26.90M 10-Q · filed 2023-10-19 |
| 2023-03-31 | $28.70M 10-Q · filed 2023-05-22 |
| 2022-12-31 | $28.47M 10-Q · filed 2023-10-19 |
| 2022-09-30 | $22.62M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $20.29M 10-Q · filed 2022-08-03 |
| 2022-03-31 | $21.16M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $27.56M 10-K · filed 2023-04-17 |
| 2021-09-30 | $25.83M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $26.21M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $24.42M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $25.30M 10-K · filed 2022-03-29 |
| 2020-09-30 | $20.54M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $20.59M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $21.09M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $52.84M 10-K · filed 2021-03-11 |
| 2019-09-30 | $50.91M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $40.24M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $43.88M 10-Q · filed 2019-05-10 |
| 2018-12-31 | $41.79M 10-K · filed 2020-03-12 |
| 2018-09-30 | $16.02M 10-Q · filed 2018-11-06 |
| 2018-06-30 | $12.12M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $12.02M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $13.70M 10-K · filed 2019-03-12 |
| 2017-09-30 | $16.76M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $17.12M 10-Q · filed 2017-08-07 |
| 2017-03-31 | $16.23M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $15.98M 10-K · filed 2018-03-16 |
| 2015-12-31 | $9.01M 10-K · filed 2017-03-24 |